The US Food and Drug Administration (FDA) has approved the first generic versions of Strattera (atomoxetine, Eli Lilly) to treat children and adults with attention ...

Dec. 20, 2004 — The U.S. Food and Drug Administration (FDA) has warned healthcare professionals via a talk paper of changes to the safety labeling for atomoxetine (Strattera, made by Eli Lilly), ...

The Food and Drug Administration on Tuesday approved four drugmakers’ generic versions of Strattera — Eli Lilly’s attention-deficit/hyperactivity disorder drug ...

FDA approves generic forms of Strattera The generic forms of Strattera are the first to be approved by the FDA for the treatment of ADHD. The US Food and Drug Administration (FDA) has approved the ...

CHICAGO, Jan 26 (Reuters) - Drugs for attention deficit hyperactivity disorder can cause children to have hallucinations even when taken as directed, U.S. government researchers said on Monday. U.S.